[在用dupilumab治疗的患者中出现非典型的膜结肠炎,系统性影响]
L Jacquel1, B Hoellinger2, G Marzolf3
1Service de médecine interne et d'immunologie clinique, Centre national de référence pour les maladies auto-immunes et systémiques (CNR RESO), Centre de compétences pour les déficits immunitaires primitifs, hôpitaux universitaires de Strasbourg, Strasbourg, France.
概括
气泡状球菌,一种寄生虫感染,可以在免疫受损的个体中呈现异常. 这一案例凸显了在患有异常肝脏和肺部病变的患者中考虑这种疾病的重要性.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 气泡状球结肠杆菌是一种由 Echinococcus multilocularis 引起的寄生性疾病.
- 它在特定的北半球地区普遍存在,并且往往被诊断不足.
- 这种疾病可以影响多个器官系统,特别是在免疫功能低下或老年患者.
研究的目的:
- 报告一种非典型呈现的膜球菌病例.
- 讨论dupilumab在疾病演变和表现中的作用.
- 强调在差异诊断中考虑膜球结肠病的重要性.
主要方法:
- 一个82岁的免疫受损患者的病例介绍.
- 对非典型肝脏和肺部病变的诊断评估.
- 分子诊断以确认 Echinococcus multilocularis 感染的情况.
主要成果:
- 非典型的肝脏和肺病变最初被怀疑是结核病或IgG4相关疾病.
- 气泡状球结肠病被诊断并通过分子方法证实.
- 由于皮质类固醇和dupilumab,患者的免疫功能受损状态影响了非典型的呈现.
结论:
- 在涉及肝脏和肺部的全身性疾病的情况下,应系统地考虑气膜内球结核病.
- 患有异常病变的免疫功能低下患者需要对这种寄生虫感染的高度怀疑指数.
- 由dupilumab诱导的特异性免疫抑制可能会导致气管内球菌的非典型表现.
相关概念视频
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...


